Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis
Free
Log In
Overview
Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis
This Activity for
- Resident / Fellow
- Physician
- Pharmacy
- Clinical Pharmacy
What I will learn?
Communicate Baricitinib and Ixekizumab value proposition in a speaker program setting in order to communicate what the product may mean to people living with Rheumatoid Arthritis Psoriatic Arthritis and Ankylosing Spondylarthritis diseases
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Transition from Clinical Trials into RWE in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylarthritis Certificate | Certificate | Free |
VAT 15% Included